Presentations by Robert Montgomery

• Wed-14 from 08:00 - 09:30 in room D
  Barriers to clinical application
  Ethical challenges in the development of models for clinical xenotransplantation
• Sun-11 from 08:00 - 09:30 in room C2
  PGC clinical: Immunosuppression and immunology
  A primer on DSA management pre- and post- transplant
• Mon-12 from 17:35 - 18:35 in room CF-7
  Models, mechanisms & therapies
  Antibody response and cellular phenotyping in kidney transplant recipients following SARS-CoV-2 vaccination
• Tue-13 from 17:35 - 18:35 in room CF-4
  Pancreas 2
  Longitudinal monitoring of pancreas and kidney transplant recipients using donor-derived cell-free DNA
• Mon-12 from 17:35 - 18:35 in room CF-10
  COVID-19 - outcome evaluation
  The impact of monoclonal antibody against SARS-CoV2 and vaccination on outcomes in kidney transplant recipients with COVID-19
• Tue-13 from 13:20 - 14:20 in room TBD
  Lunch with the Experts
  -
• Wed-14 from 13:15 - 14:15 in room A
  Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation
  Xenotransplantation: the NYU experience and the potential of dd-cfDNA as a biomarker for surveillance